Table 1.
Pt. # | Age (years) | SEX | RAI staging | B2M | IgHv mutational status | FISH | ALC | % of leukemia cells |
---|---|---|---|---|---|---|---|---|
1 | 60 | Mal | 4 | 9.6 | UM | Negative | 15.13 | 73 |
2 | 64 | F | 2 | 4.4 | M | Negative | 19.6 | 70 |
3 | 47 | F | 2 | 4.5 | UM | 17p | 182 | 93 |
5 | 77 | M | 2 | 2.7 | UM | Negative | 14.43 | 82 |
6 | 60 | M | 4 | 5.3 | UM | 11q,13q | 26.28 | 93 |
7 | 43 | M | 3 | 2.2 | UM | Negative | 38.5 | 89 |
8 | 60 | M | 3 | 3.8 | ND | 11q,13q | 79 | 95 |
9 | 49 | M | 3 | 2.6 | UM | 17p,11q,13q | 83.8 | 94 |
10 | 68 | M | 4 | 6.4 | M | 11q,13q | 53 | 91 |
12 | 44 | F | 3 | 4 | UM | Negative | 124 | 95 |
13 | 62 | M | 1 | 1.6 | M | 13q | 8.81 | 52 |
14 | 65 | M | 0 | 2.3 | M | del13q | 6.34 | 42 |
15 | 64 | M | 0 | 1.4 | M | T12 | 17.07 | 85 |
16 | 51 | M | 2 | 3.3 | UM | 11q,13q | 24 | 80 |
17 | 66 | M | 2 | 4.1 | UM | 11q | 158.3 | 93 |
18 | 54 | M | 2 | 2.2 | UM | 13q | 124 | 92 |
19 | 60 | M | 4 | 9.6 | UM | Negative | 15.13 | 72 |
Pt, patient; B2M, beta 2 microglobulin; IgHv, immunoglobulin heavy chain; FISH, Florescence in-situ hybridization; ALC absoloute lymphocyte counts; UM, unmutated; ND, not done; M, mutated;